Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Prevention of Post-ERCP Pancreatitis
NCT01060826Phase 3Unknown
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- May 2009
- Primary completion
- May 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatostatin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Status: unknown.
02
Drugs
somatostatin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT01060826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060826.